These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4981613)

  • 21. Drug resistance of Mycobacterium tuberculosis in Chandigarh.
    Mahajan RC; Agarwal SC
    Indian J Med Res; 1968 Aug; 56(8):1180-7. PubMed ID: 4179833
    [No Abstract]   [Full Text] [Related]  

  • 22. Interaction aspects of antimycobacterial drugs in the chemotherapy of tuberculosis. II. The role of rifampicin and other drugs in the dependent or independent action of drug associations in vitro.
    Trnka L; Mison P; Staflova S
    Chemotherapy; 1974; 20(2):82-91. PubMed ID: 4210894
    [No Abstract]   [Full Text] [Related]  

  • 23. [Bacteriostatic action of isonicotyl hydrazone-phospho-5'-pyridoxal on M.tuberculosis in vitro].
    Gonnard P; Ayoun M
    Rev Fr Etud Clin Biol; 1968 Oct; 13(8):802-5. PubMed ID: 4975199
    [No Abstract]   [Full Text] [Related]  

  • 24. Isoniazid activity is terminated by bacterial persistence.
    Mitchison DA; Jindani A; Davies GR; Sirgel F
    J Infect Dis; 2007 Jun; 195(12):1871-2; author reply 1872-3. PubMed ID: 17492605
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of susceptibility of Mycobacterium bovis to antituberculous drugs by radiometric BACTEC 460TB system.
    Cavirani S; Fanti F; Benecchi M; Calderaro A; Taddei S; Arcangeletti C; Medici MC; Dettori G; Chezzi C
    New Microbiol; 2003 Apr; 26(2):181-6. PubMed ID: 12737201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of a streptomycin-resistant Mycobacterium bovis strain through antitubercular drug susceptibility testing of Tunisian Mycobacterium tuberculosis complex isolates from cattle.
    Djemal SE; Camperio C; Armas F; Siala M; Smaoui S; Messadi-Akrout F; Gdoura R; Marianelli C
    BMC Vet Res; 2018 Sep; 14(1):296. PubMed ID: 30268120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Broadband" proteomics tackles TB.
    Thompson AH
    J Proteome Res; 2006 Jan; 5(1):13. PubMed ID: 16435444
    [No Abstract]   [Full Text] [Related]  

  • 28. A new disc technique for drug sensitivity test of tubercle bacilli.
    Kudoh S; Kudoh T; Yoshikawa S
    Acta Tuberc Pneumol Scand; 1965; 46(3):207-19. PubMed ID: 4956376
    [No Abstract]   [Full Text] [Related]  

  • 29. Cutting costs on mono-resistant tuberculosis diagnosis could eventually end up being more expensive.
    Rouzaud F; Robledo J
    Indian J Med Microbiol; 2010; 28(4):412-3. PubMed ID: 20966587
    [No Abstract]   [Full Text] [Related]  

  • 30. Utility of pyruvate medium for isolation of M. bovis and M. tuberculosis resistant to INH.
    Naganathan N; Rajalakshmi R
    Indian J Med Res; 1977 Oct; 66(4):556-61. PubMed ID: 415971
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug resistance and speed of growth of M. tuberculosis. I. Growth on drug-free medium.
    Zykov MP; Donets JI
    Jpn J Tuberc Chest Dis; 1971 Jul; 17(1):35-9. PubMed ID: 4113511
    [No Abstract]   [Full Text] [Related]  

  • 32. Coresistance to isoniazid and ethionamide maps to mycothiol biosynthetic genes in Mycobacterium bovis.
    Vilchèze C; Av-Gay Y; Barnes SW; Larsen MH; Walker JR; Glynne RJ; Jacobs WR
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4422-3. PubMed ID: 21709101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editor's choice: Implications of isoniazid resistance in Mycobacterium bovis Bacillus Calmette-Guérin used for immunotherapy in bladder cancer.
    Watts MR; Taylor PC; Sintchenko V; Whelan CM; Farnsworth RH; Jones P; Jelfs P; Carr D; Goldberg H
    Clin Infect Dis; 2011 Jan; 52(1):86-8. PubMed ID: 21148524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Blood bacteriostatic activity in patients with respiratory tuberculosis].
    Manicheva OA; Vishnevskiĭ BI; Ivanova LI; Pavlova MV; Archakova LI
    Probl Tuberk; 2001; (8):24-6. PubMed ID: 11767384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Testing Mycobacterium tuberculosis for drug sensitivity using different methods].
    Skriagina EM; Zalutskaia OM; Roth A; Mauch H; Nikolenko EN
    Probl Tuberk; 2001; (5):43-5. PubMed ID: 11588962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
    Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
    Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistence, not resistance, is the cause of loss of isoniazid effect.
    Wallis RS; Palaci M; Eisenach K
    J Infect Dis; 2007 Jun; 195(12):1870-1; author reply 1872-3. PubMed ID: 17492604
    [No Abstract]   [Full Text] [Related]  

  • 38. [Repeating of sensitivity tests with tuberculosis bacteria].
    Fodor T
    Prax Pneumol; 1971 Apr; 25(4):205-11. PubMed ID: 4995325
    [No Abstract]   [Full Text] [Related]  

  • 39. Transmission of isoniazid-resistant tuberculosis.
    Borgdorff MW
    J Infect Dis; 2004 Aug; 190(3):650; author reply 650-1. PubMed ID: 15243944
    [No Abstract]   [Full Text] [Related]  

  • 40. [Study of the antitubercular activity of new derivatives of aromatic hydrazides. IX. Antitubercular activity in vitro of several new substituted isonicotinoylhydrazides, diphenylsulfonylhydrazides and diphenylsulfonylhydrazidones].
    Teitel A; Stroescu V; Demetrescu C; Beneş H; Chiriţă C; Gane P; Steflea D; Chiculescu O
    Fiziol Norm Patol; 1967; 13(6):551-60. PubMed ID: 4969837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.